STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
Bristol Myers Squibb
A news roundup for Bristol Myers Squibb. BMS is a biopharmaceutical company based in Princeton, N.J., and offers prescription medications and biologics for diabetes, hepatitis, cancer, HIV/AIDS, cardiovascular disease, arthritis, and psychiatric disorders. It is one of the world’s largest pharmaceutical companies and had 2022 revenues in excess of $46 billion.
Latest
STAT Plus: After 10 years of game-changing immunotherapies, a cancer conference celebrates — and sees more work to do
STAT Plus: Late-stage results set up Cytokinetics heart drug to compete with Bristol
STAT Plus: Bernie Sanders targets ‘outrageously high price’ of Ozempic
STAT Plus: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future
STAT Plus: In a showy hearing, Bernie Sanders gets few answers about lower drug prices
STAT Plus: At JPM, Bristol’s new CEO appeals to history to try to soothe investors’ nerves
STAT Plus: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
All Coverage
advertisement
